在不可切除的肝细胞癌中,肝移植前的免疫疗法:一个病例报告
Hyejee Ohm1, Raida Khwaja2, Hatim Karachiwala3
1Department of Internal Medicine, University of Alberta, Edmonton, Alberta, Canada.
Journal of gastrointestinal oncology
|January 10, 2024
概括
在肝移植前接受免疫检查点抑制剂的肝细胞癌患者显示出积极的结果. 这种治疗是一种可行的移植前选择,不会导致移植器官的排斥,并可能延长供体器官的资格.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 肝移植是治疗HCC的唯一方法.
- 免疫检查点抑制剂 (ICI) 改善了晚期HCC的存活率,但移植前的数据有限.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Tissue Transplantation
372
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
372


